Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Eurobio Scientific SA (ALEHT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6615
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves a range of therapeutic areas including infectious diseases, Alzheimer’s disease and cancer. The company commercializes in vitro diagnostic kits and instruments through its affiliate Ingen. It has presence in France and the US. Eurobio is headquartered in Paris, France.

Eurobio Scientific SA (ALEHT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Eurobio Scientific SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Eurobio Scientific SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Eurobio Scientific SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Eurobio Scientific SA, Medical Equipment, Deal Details 10
Partnerships 10
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 10
Diaxonhit and Advanced Biological Labs Enter into Distribution Agreement 11
Ingen Expands Distribution Agreement with One Lambda 12
InGen BioSciences Enters Into Distribution Agreement With Quidel 13
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14
InGen BioSciences Enters Into Co-Marketing Agreement With Cylex For ImmuKnow Assays 15
Equity Offering 16
Diaxonhit to Raise USD9.5 Million in public offering of shares 16
Diaxonhit to Raise Funds through Private Placement of Shares 17
Exonhit Completes First Tranche Of Private Placement Of Shares For US$2 Million 18
Acquisition 19
Diaxonhit to Acquire GenBio for USD2 Million 19
Exonhit Completes Acquisition Of InGen BioSciences From Innoven Partenaires And Amundi Private Equity For US$23 Million 20
Eurobio Scientific SA – Key Competitors 22
Eurobio Scientific SA – Key Employees 23
Eurobio Scientific SA – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Jun 30, 2018: Eurobio Scientific announce 2018 mid year results 25
Other Significant Developments 26
Jul 23, 2018: Eurobio Scientific: 2018 mid-year activity report 26
Feb 15, 2018: Diaxonhit: Exclusive distribution of the VERIGENE molecular biology platform 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Eurobio Scientific SA, Medical Equipment, Key Facts, 2017 2
Eurobio Scientific SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Eurobio Scientific SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Eurobio Scientific SA, Deals By Market, 2012 to YTD 2018 8
Eurobio Scientific SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 10
Diaxonhit and Advanced Biological Labs Enter into Distribution Agreement 11
Ingen Expands Distribution Agreement with One Lambda 12
InGen BioSciences Enters Into Distribution Agreement With Quidel 13
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14
InGen BioSciences Enters Into Co-Marketing Agreement With Cylex For ImmuKnow Assays 15
Diaxonhit to Raise USD9.5 Million in public offering of shares 16
Diaxonhit to Raise Funds through Private Placement of Shares 17
Exonhit Completes First Tranche Of Private Placement Of Shares For US$2 Million 18
Diaxonhit to Acquire GenBio for USD2 Million 19
Exonhit Completes Acquisition Of InGen BioSciences From Innoven Partenaires And Amundi Private Equity For US$23 Million 20
Eurobio Scientific SA, Key Competitors 22
Eurobio Scientific SA, Key Employees 23
Eurobio Scientific SA, Other Locations 24
Eurobio Scientific SA, Subsidiaries 24

List of Figures
Eurobio Scientific SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Eurobio Scientific SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Eurobio Scientific SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virginia Electric and Power Company:発電所・企業SWOT分析
    Virginia Electric and Power Company – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Panther Energy Company LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Panther Energy Company LLC (PEC) is an oil and gas company that offers drilling services. The company’s business activities include exploration, acquisition, development and production of oil, natural gas liquids and natural gas. It carries out grassroots horizontal exploration of unconventi …
  • Partner Reinsurance Asia Pte. Ltd.
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Pacific Energy Ltd (PEA):企業の財務・戦略的SWOT分析
    Summary Pacific Energy Ltd (PEL) operates as a power generation company that develops, operates and maintains renewable energy power stations. The company operates Kalgoorlie Power Systems that operates site locations across Northern Territory, Western Australia and South Australia, among others. It …
  • HedgePath Pharmaceuticals Inc (HPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Hedgepath Pharmaceuticals Inc (Hedgepath), a subsidiary of Mayne Pharma Group Ltd, is a clinical stage biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of skin, prostrate, and lung cancers. The company is investigating an oral formula …
  • TiVo Corporation (TIVO):企業の財務・戦略的SWOT分析
    TiVo Corporation (TIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Stellar Biotechnologies Inc (SBOT):企業の財務・戦略的SWOT分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • Caixa Geral de Depositos, SA:企業の戦略的SWOT分析
    Caixa Geral de Depositos, SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • NTPC Ltd (NTPC):企業の財務・戦略的SWOT分析
    NTPC Ltd (NTPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kirin Holdings Co Ltd:戦略・SWOT・企業財務分析
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cub Energy Inc (KUB):企業の財務・戦略的SWOT分析
    Summary Cub Energy Inc (Cub Energy), formerly 3P International Energy Corp is an oil and gas company that explores and develops oil and gas assets in Ukraine. The company operates its oil and gas exploration assets in Transcarpathian Basin and Dnieper-Donets Basin. Cub Energy uses technologies such …
  • AcuFocus Inc:医療機器:M&Aディール及び事業提携情報
    Summary AcuFocus Inc (AcuFocus) is an ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company develops and markets breakthrough technologies for the improvement of vision. It’s IC-8 IOL, a small aperture lens that is designed for preby …
  • Aesculap Inc-医療機器分野:企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Provimi Holding BV:企業の戦略・SWOT・財務分析
    Provimi Holding BV - Strategy, SWOT and Corporate Finance Report Summary Provimi Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Etihad Aviation Group PJSC:企業の戦略・SWOT・財務情報
    Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report Summary Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PT Bumi Resources Tbk:企業のM&A・事業提携・投資動向
    PT Bumi Resources Tbk - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PT Bumi Resources Tbk Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Censo Biotechnologies Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays; …
  • Woori Bank:企業のM&A・事業提携・投資動向
    Woori Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Woori Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆